EcoDrugPlus

Matrix Metallopeptidase 1

Ensembl ID : ENSCDRG00005001400
Gene Symbol: MMP1
3 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSCDRG00005001447
Gene Symbol: MMP12
3 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSCDRG00005001466
Gene Symbol: MMP13
3 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSCDRG00005007391
Gene Symbol: MMP14
1 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCDRG00005001638
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSCDRG00005001425
Gene Symbol: MMP3
3 Cross references
502 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSCDRG00005001294
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSCDRG00005001367
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCDRG00005019520
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCDRG00005016546
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSCDRG00005017174
Gene Symbol: MC3R
3 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCDRG00005019025
Gene Symbol: MC4R
1 Cross references
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).